China SXT Pharmaceuticals, Inc. SXTC

Company Overview

China SXT Pharmaceuticals, Inc. is a specialty pharmaceutical company primarily engaged in the research, development, manufacturing, marketing, and distribution of traditional Chinese medicine (TCM) products, including herbal-based prescription drugs, over-the-counter medicines, and dietary supplements. The company operates within the pharmaceuticals and nutraceuticals industries, with a focus on therapies derived from traditional Chinese medicinal formulations adapted for modern clinical and consumer use.

The company’s core revenue drivers are its portfolio of TCM prescription medicines, OTC products, and herbal dietary supplements, which are sold mainly through hospitals, pharmacies, and distributors in China. China SXT positions itself by combining established TCM formulas with standardized manufacturing and regulatory compliance, seeking to address demand for both conventional and alternative healthcare products. Founded in 1996, the company evolved from a regional TCM producer into a publicly listed entity, completing its U.S. listing through a reverse merger and later trading on NASDAQ under the ticker SXTC.